Latest Insider Transactions at Repligen Corp (RGEN)
This section provides a real-time view of insider transactions for Repligen Corp (RGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REPLIGEN CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REPLIGEN CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 14
2021
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
710
-2.81%
|
$122,120
$172.29 P/Share
|
|
May 14
2021
|
Christine Gebski |
SELL
Open market or private sale
|
Direct |
445
-1.2%
|
$76,540
$172.25 P/Share
|
|
May 13
2021
|
Karen A Dawes |
BUY
Grant, award, or other acquisition
|
Direct |
604
+0.52%
|
-
|
|
May 13
2021
|
Rohin Mhatre |
BUY
Grant, award, or other acquisition
|
Direct |
457
+50.0%
|
-
|
|
May 13
2021
|
Thomas F Ryan Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+20.7%
|
-
|
|
May 13
2021
|
Nicolas Barthelemy |
BUY
Grant, award, or other acquisition
|
Direct |
457
+19.33%
|
-
|
|
May 13
2021
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
457
+6.7%
|
-
|
|
May 13
2021
|
Manner Carrie Eglinton |
BUY
Grant, award, or other acquisition
|
Direct |
457
+50.0%
|
-
|
|
May 11
2021
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
285
-0.25%
|
$50,160
$176.85 P/Share
|
|
May 11
2021
|
Karen A Dawes |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+11.47%
|
$45,000
$3.22 P/Share
|
|
Apr 06
2021
|
James Bylund Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
360
-5.39%
|
$73,440
$204.25 P/Share
|
|
Mar 16
2021
|
Christine Gebski |
SELL
Open market or private sale
|
Direct |
1,400
-3.63%
|
$274,400
$196.88 P/Share
|
|
Mar 12
2021
|
Thomas F Ryan Jr Director |
SELL
Bona fide gift
|
Direct |
170
-11.61%
|
-
|
|
Mar 12
2021
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
9,102
-0.6%
|
$1,738,482
$191.11 P/Share
|
|
Mar 10
2021
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
8,000
-8.44%
|
$1,528,000
$191.18 P/Share
|
|
Mar 10
2021
|
Ralf Kuriyel Senior VP, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+7.43%
|
$336,000
$42.15 P/Share
|
|
Mar 04
2021
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
2,075
-1.56%
|
$398,400
$192.81 P/Share
|
|
Mar 04
2021
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,545
-1.47%
|
$684,185
$193.15 P/Share
|
|
Mar 04
2021
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
21,900
-1.04%
|
$4,182,900
$191.48 P/Share
|
|
Mar 03
2021
|
Thomas F Ryan Jr Director |
SELL
Open market or private sale
|
Direct |
1,000
-40.58%
|
$205,000
$205.0 P/Share
|
|
Mar 03
2021
|
Thomas F Ryan Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+28.87%
|
$26,000
$26.12 P/Share
|
|
Feb 24
2021
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
10,437
+4.11%
|
-
|
|
Feb 24
2021
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
1,686
+5.81%
|
-
|
|
Feb 24
2021
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,410
+6.29%
|
-
|
|
Jan 25
2021
|
Jon Snodgres Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+10.67%
|
$132,000
$33.87 P/Share
|
|
Jan 04
2021
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,957
-1.77%
|
$759,744
$192.4 P/Share
|
|
Dec 16
2020
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
435
-1.67%
|
$80,910
$186.18 P/Share
|
|
Nov 19
2020
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
20,000
-2.03%
|
$3,720,000
$186.12 P/Share
|
|
Nov 19
2020
|
Anthony Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+7.32%
|
$520,000
$26.05 P/Share
|
|
Nov 11
2020
|
Thomas F Ryan Jr Director |
SELL
Open market or private sale
|
Direct |
934
-38.95%
|
$174,658
$187.73 P/Share
|
|
Nov 11
2020
|
Thomas F Ryan Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
934
+28.03%
|
$35,492
$38.76 P/Share
|
|
Nov 10
2020
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,086
-8.45%
|
$595,598
$193.0 P/Share
|
|
Nov 10
2020
|
Jon Snodgres Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,086
+7.79%
|
$98,752
$32.4 P/Share
|
|
Nov 09
2020
|
Jon Snodgres Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,893
+5.36%
|
$111,687
$59.52 P/Share
|
|
Nov 09
2020
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
705
-2.18%
|
$136,770
$194.69 P/Share
|
|
Nov 09
2020
|
Nicolas Barthelemy |
SELL
Open market or private sale
|
Direct |
1,214
-45.57%
|
$236,730
$195.51 P/Share
|